Xencor (XNCR) Market Update – 21 Oct 2026
- Closing Price (24 h ending 01:07 AM CET): Xencor shares closed up 1.49 %.
- Current Trading Price: Approximately USD 24.94 per share on major exchanges.
- Shares Outstanding: 74.4 million shares.
- Market Capitalisation: USD 1.7 billion.
- 24‑Hour Trading Volume: Roughly USD 47.2 million worth of shares were exchanged.
- Performance Since Last Month‑End: Down 7.35 %.
- 200‑Day Simple Moving Average (SMA): USD 16.35.
- 52‑Week High: USD 30.61 (recorded on 25 Aug 2026).
- 52‑Week Low: USD 10.38 (recorded on 19 May 2026).
24‑Hour Performance of Related Stocks
| Symbol | Recent % Change | Current Price (USD) | Market Cap (USD) |
|---|---|---|---|
| FRMI (Fermi) | –4.43 % | 2.94 | 2 billion |
| WS (Worthington Steel) | +4.99 % | 41.24 | 2 billion |
| SLS (Sellas Life Sciences I) | +5.11 % | 12.00 | 2 billion |
| AXGN (Axogen) | +1.79 % | 36.17 | 2 billion |
| VERA (Vera Therapeutics) | +3.73 % | 30.06 | 2 billion |
Company Overview
Xencor, Inc. is a biotechnology firm focused on the development of antibody and protein therapeutics for the treatment of cancer and autoimmune inflammation. The company distributes its products to healthcare providers and facilities worldwide. Xencor’s official website is www.xencor.com . The company’s shares are listed on the Nasdaq stock exchange. Xencor completed its initial public offering on 3 December 2013.
